2020 annual financial data

Redhill Biopharma 2020 Financial results

Direct answer

Revenue was 64,359,000 USD.

Operating income was -63,684,000 USD and net income was -76,173,000 USD.
Operating cash flow was -48,579,000 USD.

Get free Redhill Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
64,359,000 USD
Operating income
-63,684,000 USD
Net income
-76,173,000 USD
Operating cash flow
-48,579,000 USD